| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ETOPOSIDE | 5 |
| 2 | IFOSFAMIDE | 4 |
| 3 | IFOSFAMIDE FOR INJECTION | 4 |
| 4 | INTERFERON BETA-1A | 4 |
| 5 | PACLITAXEL | 4 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 4 |
| 7 | AZATHIOPRINE | 3 |
| 8 | CARBOPLATIN | 3 |
| 9 | INFLIXIMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALIFERMIN | 1 | 0.0026 |
| 1 | IFOSFAMIDE FOR INJECTION | 4 | 0.0002 |
| 2 | BLEOMYCIN SULFATE | 1 | 0.0001 |
| 3 | PEGFILGRASTIM | 1 | 0.0001 |
| 4 | BISACODYL SUPPOSITORIES | 1 | 0.0001 |
| 5 | BISCODYL | 1 | 0.0001 |
| 6 | BISACODYL | 1 | 0.0001 |
| 7 | ETOPOSIDE | 5 | 0.0001 |
| 8 | LACTULOSE | 2 | 0.0001 |
| 9 | SOMATROPIN | 3 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 5 |
| 1 | Topoisomerase Inhibitor [EPC] | 5 |
| 2 | Alkylating Drug [EPC] | 4 |
| 3 | Interferon beta [EPC] | 4 |
| 4 | Microtubule Inhibitor [EPC] | 4 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 6 | Corticosteroid [EPC] | 3 |
| 7 | Purine Antimetabolite [EPC] | 3 |
| 8 | Atypical Antipsychotic [EPC] | 2 |
| 9 | Integrin Receptor Antagonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 2 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Purine Antimetabolite [EPC] | 3 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 8 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 9 | Interferon beta [EPC] | 4 | 0.0000 |